Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa.

ABSTRACT:

Background

Tuberculosis (TB) is the leading cause of death among people with HIV and a major global health challenge. Subclinical cardiovascular manifestations of TB are poorly documented in high TB and HIV burden countries.

Objectives

The purpose of this study was to quantify the prevalence of cardiovascular involvement in TB patients and investigate changes after completion of anti-TB treatment.

Methods

HIV-positive and HIV-negative patients diagnosed with pulmonary TB between October 2022 and November 2023 were enrolled from 2 tertiary care hospitals in Zambia and South Africa. Standardized transthoracic echocardiography (TTE) was conducted at TB diagnosis and after 6 months of anti-TB treatment. Cross-sectional and longitudinal analyses assessed pericardial effusi

SUBMITTER: Samim D 

PROVIDER: S-EPMC11667022 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature